The UNH stock price on the Vantage UNH CFD was at $405.55 as of 07:13 UTC (15:13 GMT+8) on 12 June 2026, down 0.47% on the session. UnitedHealth Group has now recovered more than 70% from its early-2026 low near $235. The daily chart on the TradingView setup used for this analysis shows price holding above both its 50-period and 200-period daily moving averages. All prices reference the Vantage UNH CFD feed. This is not financial advice.

Key points

• UNH last traded at $405.55 on 12 June 2026, trading above both the 50-day MA (331.04) and 200-day MA (361.04), with the daily RSI at 66.48 per the TradingView setup used for this analysis.
• JPMorgan raised its price target to $466 on 8 June 2026 – the highest on the Street – while BofA ($450) and Morgan Stanley ($453) also revised upward in the same week.^[1]
• Q1 2026 adjusted EPS of $7.23 beat consensus by roughly 10%, the medical care ratio improved to 83.9% from 84.8% a year earlier, and Q2 2026 earnings are scheduled for 16 July 2026.^[2]

What the UNH daily chart shows

UNH share price collapsed from its all-time high near $603 in late 2024 to a trough below $237 in early 2026, as the CEO resigned, the company withdrew its earnings guidance, and a DOJ review of Medicare billing practices weighed on sentiment.^[3]

Since then, the stock has staged a sustained recovery. Price is now trading roughly $44 above the 200-period daily MA at 361.04, itself still rising. The 50-period daily MA at 331.04 sits further below, underscoring how far momentum has run since the lows.

The RSI (14, close) on the TradingView setup used for this analysis stands at 66.48 – elevated but below the overbought readings above 80 seen in late April and early May 2026. The day range was $403.11 to $409.98, with price having reached a recent intraday peak of $413 on 9 June 2026, within a 52-week range of $234.70 to $415.97 per Morningstar data.^[4]

What is driving the UnitedHealth Group stock recovery

Q1 2026 earnings beat

UnitedHealth reported Q1 2026 revenue of $111.7 billion and adjusted EPS of $7.23, roughly 10% above consensus.^[2] The medical care ratio improved to 83.9% from 84.8% a year earlier. Operating cash flow reached $8.9 billion. Management guided for nearly $1.5 billion in AI investment for 2026, with call-centre volume at OptumRx already down 25% through digital and AI-enabled self-service, and digital prior authorisations running at a 96% approval rate.

CMS Medicare Advantage rate decision

On 6 April 2026, the Centers for Medicare and Medicaid Services (CMS) finalised a 2.48% net average rate increase for Medicare Advantage (MA) plans for 2027 – far above the 0.09% proposed in January.^[5] UNH, as the largest MA provider in the US, saw shares jump more than 7% on the day. Industry estimates suggest the decision could inject more than $13 billion in additional funding into the Medicare Advantage programme.

Analyst upgrade cycle

Six major institutions raised their price targets between late May and early June 2026. JPMorgan issued the highest published target at $466 on 8 June 2026.^[1] Mizuho followed within the hour at $460, citing a calmer policy outlook. BofA ($450) and Morgan Stanley ($453) upgraded earlier in the same week.^[6] UNH also raised its quarterly dividend 5% to $2.32, payable 23 June 2026.

Key levels on the UNH share price chart

Table 1: UNH key levels as of 12 June 2026, 07:13 UTC. Source: TradingView, Vantage UNH CFD feed. Indicative only.

What to watch next

• Q2 2026 earnings, 16 July 2026: Analysts estimated adjusted EPS of approximately $4.84 and revenue of around $110.8 billion, per Benzinga consensus data as of 12 June 2026.^[7] Medical care ratio trend and any DOJ update will be in focus.
• Dividend ex-date, 15 June 2026: UNH trades ex-dividend on 15 June; $2.32 per share payable 23 June 2026.
• DOJ review: The Justice Department’s review of Medicare billing remains unresolved. Any material update is likely to move the UNH stock price sharply.

The UNH CFD intraday range has widened relative to earlier in the year. The upcoming Q2 2026 earnings report on 16 July 2026 is a scheduled event that can move the unitedhealth group stock price materially in a short window. The Stop Loss academy page at Vantage has further reading on how Stop Loss orders work in CFD trading.

Leverage amplifies both gains and losses when trading share CFDs. It is a double-edged tool. The position sizing and leverage pages in the Vantage Academy explain how these concepts apply to CFD trading.

RISK WARNING: CFDs are complex financial instruments and carry a high risk of losing money rapidly due to leverage. You should ensure you fully understand the risks involved and carefully consider whether you can afford to take the high risk of losing your money before trading.

Disclaimer: The information is provided for educational purposes only and does not take into account your personal objectives, financial circumstances, or needs. It does not constitute investment advice. We encourage you to seek independent advice if necessary. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research. No representation or warranty is given as to the accuracy or completeness of any information contained within. This material may contain historical or past performance figures and should not be relied on. Furthermore estimates, forward-looking statements, and forecasts cannot be guaranteed. The information on this site and the products and services offered are not intended for distribution to any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

References

[1] “JPMorgan resets UnitedHealth stock target for 2026 – TheStreet” https://www.thestreet.com/investing/stocks/jpmorgan-resets-unitedhealth-stock-target-for-2026 Accessed on 12 June 2026.

[2] “UnitedHealth Group Inc (UNH) Q1 2026 Earnings Call Highlights – Yahoo Finance” https://finance.yahoo.com/sectors/healthcare/articles/unitedhealth-group-inc-unh-q1-070136214.html Accessed on 12 June 2026.

[3] “UnitedHealth’s Comeback Nobody Expected – Seeking Alpha” https://seekingalpha.com/article/4910837-unitedhealth-stock-comeback-nobody-expected Accessed on 12 June 2026.

[4] “UnitedHealth Group (UNH) Stock Quote – Morningstar” https://www.morningstar.com/stocks/xnys/unh/quote Accessed on 12 June 2026.

[5] “Medicare Advantage 2027 payment update increases after a CMS revision – HFMA” https://www.hfma.org/payment-reimbursement-and-managed-care/medicare-advantage-payment-update-2027/ Accessed on 12 June 2026.

[6] “Is UNH Stock Set For Another 12% Rally? – Stocktwits” https://stocktwits.com/news-articles/markets/equity/unh-stock-rise-wall-street-analysts-rating-price-target-raise/cZ0Z065ReyM Accessed on 12 June 2026.

[7] “UnitedHealth Group Earnings Estimates – Benzinga” https://www.benzinga.com/quote/UNH/earnings Accessed on 12 June 2026.